1. Home
  2. GCBC vs PBYI Comparison

GCBC vs PBYI Comparison

Compare GCBC & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greene County Bancorp Inc.

GCBC

Greene County Bancorp Inc.

HOLD

Current Price

$29.85

Market Cap

391.8M

Sector

Finance

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$7.92

Market Cap

364.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCBC
PBYI
Founded
1889
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
391.8M
364.9M
IPO Year
1998
2011

Fundamental Metrics

Financial Performance
Metric
GCBC
PBYI
Price
$29.85
$7.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.2K
214.2K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
1.66%
N/A
EPS Growth
26.21
N/A
EPS
1.74
N/A
Revenue
$4,117,000.00
$27,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.50
N/A
Revenue Growth
11.06
N/A
52 Week Low
$21.25
$3.03
52 Week High
$30.71
$8.08

Technical Indicators

Market Signals
Indicator
GCBC
PBYI
Relative Strength Index (RSI) 67.81 65.26
Support Level $21.63 $6.21
Resistance Level $30.71 N/A
Average True Range (ATR) 1.38 0.32
MACD 0.00 0.10
Stochastic Oscillator 85.49 68.71

Price Performance

Historical Comparison
GCBC
PBYI

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: